Form 10-Q INTER PARFUMS INC For: Sep 30

Article Stock Quotes (1)

FREE Breaking News Alerts from StreetInsider.com!

StreetInsider.com Top Tickers, 4/18/2024

1. LVS
2. TSM
3. SPY
4. NFLX
5. CSX

6. UAL
7. ALK
8. EFX
9. TSLA
10. INFY

Top News Most Read Special Reports

November 9, 2015 4:40 PM EST

E-mail

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

( MARK ONE )

Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended September 30, 2015.

Transition Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from ___________to ________.

Commission File No. 0-16469

INTER PARFUMS, INC.

(Exact name of registrant as specified in its charter)

Delaware		13-3275609
(State or other jurisdiction of		(I.R.S. Employer
incorporation or organization)		Identification No.)

551 Fifth Avenue, New York, New York 10176

(Address of Principal Executive Offices) (Zip Code)

(212) 983-2640

(Registrants telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days: Yes x No ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See definition of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act).

Large accelerated Filer ¨	Accelerated filer x
Non-accelerated filer ¨ (Do not check if a smaller reporting company)	Smaller reporting company ¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ¨ No x

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

At November 6, 2015, there were 31,005,548 shares of common stock, par value $.001 per share, outstanding.

INTER PARFUMS, INC. AND SUBSIDIARIES

INDEX

			Page Number
Part I. Financial Information			1

	Item 1.	Financial Statements

		Consolidated Balance Sheets as of September 30, 2015 and December 31, 2014	2

		Consolidated Statements of Income for the Three and Nine Months Ended September 30, 2015 and September 30, 2014	3

		Consolidated Statements of Comprehensive Income (Loss) for the Three and Nine Months Ended September 30, 2015 and September 30, 2014	4

		Consolidated Statements of Changes in Equity for the Nine Months Ended September 30, 2015 and September 30, 2014	5

		Consolidated Statements of Cash Flows for the Nine Months Ended September 30, 2015 and September 30, 2014	6

		Notes to Consolidated Financial Statements	7

	Item 2.	Management's Discussion and Analysis of Financial Condition and Results of Operations	15

	Item 3.	Quantitative and Qualitative Disclosures About Market Risk	28

	Item 4.	Controls and Procedures	29

Part II. Other Information			30

	Item 6.	Exhibits	30

Signatures			30

INTER PARFUMS, INC. AND SUBSIDIARIES

Part I. Financial Information

Item 1. Financial Statements

In our opinion, the accompanying unaudited consolidated financial statements contain all adjustments (consisting only of normal recurring adjustments) necessary to present fairly our financial position, results of operations and cash flows for the interim periods presented. We have condensed such financial statements in accordance with the rules and regulations of the Securities and Exchange Commission (“SEC”). Therefore, such financial statements do not include all disclosures required by accounting principles generally accepted in the United States of America. In preparing these consolidated financial statements, the Company has evaluated events and transactions for potential recognition or disclosure through the date the consolidated financial statements were issued by filing with the SEC. These financial statements should be read in conjunction with our audited financial statements for the year ended December 31, 2014 included in our annual report filed on Form 10-K.

The results of operations for the nine months ended September 30, 2015 are not necessarily indicative of the results to be expected for the entire fiscal year.

Page 1

INTER PARFUMS, INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

(In thousands except share and per share data)

(Unaudited)

	September 30, 2015			December 31, 2014
ASSETS
Current assets:
Cash and cash equivalents	$	124,529		$	90,138
Short-term investments		90,219			190,152
Accounts receivable, net		130,244			90,124
Inventories		106,991			102,326
Receivables, other		3,445			1,542
Other current assets		5,301			4,504
Income tax receivable		51			929
Deferred tax assets		9,212			6,848
Total current assets		469,992			486,563
Equipment and leasehold improvements, net		8,712			9,187
Trademarks, licenses and other intangible assets, net		207,656			98,531
Other assets		8,543			10,225
Total assets	$	694,903		$	604,506

LIABILITIES AND EQUITY
Current liabilities:
Loans payable – banks	$	—		$	298
Current portion of long-term debt		21,975			—
Accounts payable, trade		39,322			46,646
Accrued expenses		42,530			49,194
Income taxes payable		9,186			3,773
Dividends payable		4,031			3,717
Total current liabilities		117,044			103,628
Long-term debt, less current portion		84,562			—
Deferred tax liability		4,339			2,154
Equity:
Inter Parfums, Inc. shareholders’ equity:
Preferred stock, $.001 par; authorized 1,000,000 shares; none issued		—			—
Common stock, $.001 par; authorized 100,000,000 shares; outstanding 31,005,208 and 30,977,293 shares at September 30, 2015 and December 31, 2014, respectively		31			31
Additional paid-in capital		61,235			60,200
Retained earnings		390,610			374,121
Accumulated other comprehensive (loss)		(39,915	)		(15,823	)
Treasury stock, at cost, 9,897,995 common shares at September 30, 2015 and December 31, 2014, respectively		(36,464	)		(36,464	)
Total Inter Parfums, Inc. shareholders’ equity		375,497			382,065
Noncontrolling interest		113,461			116,659
Total equity		488,958			498,724
Total liabilities and equity	$	694,903		$	604,506

See notes to consolidated financial statements.

Page 2

INTER PARFUMS, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF INCOME

(In thousands except per share data)

(Unaudited)

	Three Months Ended September 30,						Nine Months Ended September 30,
	2015			2014			2015			2014

Net sales	$	138,944		$	134,206		$	350,214		$	374,129

Cost of sales		53,118			58,878			136,453			161,455

Gross margin		85,826			75,328			213,761			212,674

Selling, general and administrative expenses		58,188			56,647			156,815			163,720

Income from operations		27,638			18,681			56,946			48,954

Other expenses (income):
Interest expense		1,041			554			1,811			1,402
(Gain) loss on foreign currency		(336	)		(1,129	)		1,751			(1,057	)
Interest income		(857	)		(915	)		(2,829	)		(2,974	)

		(152	)		(1,490	)		733			(2,629	)

Income before income taxes		27,790			20,171			56,213			51,583

Income taxes		9,156			6,407			18,754			18,003

Net income		18,634			13,764			37,459			33,580

Less: Net income attributable to the noncontrolling interest		4,414			2,651			8,881			7,465

Net income attributable to Inter Parfums, Inc.	$	14,220		$	11,113		$	28,578		$	26,115

Earnings per share:

Net income attributable to Inter Parfums, Inc. common shareholders:
Basic	$	0.46		$	0.36		$	0.92		$	0.84
Diluted	$	0.46		$	0.36		$	0.92		$	0.84

Weighted average number of shares outstanding:
Basic		31,005			30,941			30,991			30,927
Diluted		31,098			31,054			31,092			31,060

Dividends declared per share	$	0.13		$	0.12		$	0.39		$	0.36

See notes to consolidated financial statements

Page 3

INTER PARFUMS, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)

(In thousands except per share data)

(Unaudited)

	Three Months Ended September 30,						Nine Months Ended September 30,
	2015			2014			2015			2014
Comprehensive income: (loss)

Net income	$	18,634		$	13,764		$	37,459		$	33,580

Other comprehensive income (loss):

Translation adjustments, net of tax		(442	)		(37,990	)		(33,031	)		(42,620	)

Comprehensive income (loss)		18,192			(24,226	)		4,428			(9,040	)

Comprehensive income (loss) attributable to the noncontrolling interests:

Net income		4,414			2,651			8,881			7,465

Other comprehensive income (loss):

Translation adjustments, net of tax		14			(10,786	)		(8,939	)		(12,296	)

Comprehensive income (loss) attributable to the noncontrolling interests		4,428			(8,135	)		(58	)		(4,831	)

Comprehensive income (loss) attributable to Inter Parfums, Inc.	$	13,764		$	(16,091	)	$	4,486		$	(4,209	)

See notes to consolidated financial statements.

Page 4

INTER PARFUMS, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY

(In thousands)

(Unaudited)

	Nine months ended September 30,
	2015			2014

Common stock, beginning and end of period	$	31		$	31

Additional paid-in capital, beginning of period		60,200			57,877
Shares issued upon exercise of stock options		451			1,074
Sale of subsidiary shares to noncontrolling interests		(6	)		(335	)
Stock-based compensation		590			507
Additional paid-in capital, end of period		61,235			59,123

Retained earnings, beginning of period		374,121			359,459
Net income		28,578			26,115
Dividends		(12,089	)		(11,137	)
Stock-based compensation		—			79
Retained earnings, end of period		390,610			374,516

Accumulated other comprehensive income (loss), beginning of period		(15,823	)		25,860
Foreign currency translation adjustment		(24,092	)		(30,324	)
Accumulated other comprehensive income (loss), end of period		(39,915	)		(4,464	)

Treasury stock, beginning of period		(36,464	)		(36,016	)
Shares issued upon exercise of stock options		—			101
Shares received as proceeds of option exercises		—			(351	)
Treasury stock, end of period		(36,464	)		(36,266	)

Noncontrolling interest, beginning of period		116,659			128,145
Net income		8,881			7,465
Foreign currency translation adjustment		(8,939	)		(12,296	)
Sale of subsidiary shares to noncontrolling interest		696			1,365
Dividends		(3,836	)		(4,667	)
Stock-based compensation		—			30
Noncontrolling interest, end of period		113,461			120,042

Total equity	$	488,958		$	512,982

See notes to consolidated financial statements.

Page 5

INTER PARFUMS, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

(Unaudited)

	Nine months ended September 30,
	2015			2014
Cash flows from operating activities:
Net income	$	37,459		$	33,580
Adjustments to reconcile net income to net cash used in operating activities:
Depreciation and amortization		6,718			7,723
Provision for doubtful accounts		39			456
Noncash stock compensation		590			689
Deferred tax benefit		(508	)		(799	)
Change in fair value of derivatives		670			—
Changes in:
Accounts receivable		(44,778	)		(51,455	)
Inventories		(10,737	)		(3,566	)
Other assets		(2,106	)		(411	)
Accounts payable and accrued expenses		(6,189	)		(12,347	)
Income taxes, net		6,346			12,931

Net cash used in operating activities		(12,496	)		(13,199	)

Cash flows from investing activities:
Purchases of short-term investments		(56,216	)		(248,193	)
Proceeds from sale of short-term investments		141,009			214,975
Purchases of equipment and leasehold improvements		(2,500	)		(2,584	)
Payment for intangible assets acquired		(119,541	)		(821	)

Net cash used in investing activities		(37,248	)		(36,623	)

Cash flows from financing activities:
Repayments of loans payable – banks, net		—			(5,841	)
Proceeds from issuance of long-term debt		111,440			—
Repayments of long-term debt		(6,404	)		—
Proceeds from exercise of options		451			861
Proceeds from sale of stock of subsidiary		690			1,030
Dividends paid		(11,775	)		(11,128	)
Dividends paid to noncontrolling interest		(3,836	)		(4,667	)
Purchase of treasury stock		—			(37	)

Net cash provided by (used in) financing activities		90,566			(19,782	)

Effect of exchange rate changes on cash		(6,431	)		(5,861	)

Net increase (decrease) in cash and cash equivalents		34,391			(75,465	)

Cash and cash equivalents - beginning of period		90,138			125,650

Cash and cash equivalents - end of period	$	124,529		$	50,185

Supplemental disclosure of cash flow information:

Cash paid for:
Interest	$	1,688		$	1,028
Income taxes		16,692			6,396

See notes to consolidated financial statements.

Page 6

INTER PARFUMS, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

Significant Accounting Policies:

The accounting policies we follow are set forth in the notes to our financial statements included in our Form 10-K, which was filed with the Securities and Exchange Commission for the year ended December 31, 2014. We also discuss such policies in Part I, Item 2, Management’s Discussion and Analysis of Financial Condition and Results of Operations, included in this Form 10-Q.

Recent Accounting Pronouncements:

In May 2014, the Financial Accounting Standards Board (“FASB”) issued an Accounting Standards Update (“ASU”) which supersedes the most current revenue recognition requirements. The new revenue recognition standard requires entities to recognize revenue in a way that depicts the transfer of goods or services to customers in an amount that reflects the consideration which the entity expects to be entitled to in exchange for those goods or services. This guidance is effective for annual and interim reporting periods beginning after December 15, 2017, with early adoption permitted for annual periods after December 15, 2016. We are currently evaluating the standard to determine the impact of its adoption on our consolidated financial statements.

In July 2015, the FASB issued an ASU modifying the accounting for inventory. Under this ASU, the measurement principle for inventory will change from lower of cost or market value to lower of cost and net realizable value. The ASU defines net realizable value as the estimated selling price in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation. The ASU is applicable to inventory that is accounted for under the first-in, first-out method and is effective for reporting periods after December 15, 2016, with early adoption permitted. We are currently evaluating the standard to determine the impact of its adoption on our consolidated financial statements.

There are no other recent accounting pronouncements issued but not yet adopted that would have a material effect on our consolidated financial statements.

New Agreements:

In October 2015, the Company, through its majority owned Paris-based subsidiary, Interparfums SA, has extended its license agreement with Montblanc by five years. The original agreement, signed in 2010, provided Interparfums SA with the exclusive worldwide license rights to create, produce and distribute perfumes and ancillary products under the Montblanc brand through December 31, 2020. The new 10-year agreement, which goes into effect on January 1, 2016, extends the partnership through December 31, 2025 without any material changes in operating conditions from the prior license. The license agreement is subject to certain minimum sales, advertising expenditures and royalty payments as are customary in our industry.

In May 2015, the Company, through its majority owned Paris-based subsidiary, Interparfums SA, acquired the Rochas brand from The Procter & Gamble Company. This transaction includes all brand names and registered trademarks for Rochas (Femme, Madame, Eau de Rochas, etc.), mainly for class 3 (cosmetics) and class 25 (fashion). Substantially the entire €106 million purchase price for the assets acquired (approximately $118 million) was allocated to trademarks with indefinite lives, including approximately $5.4 million in acquisition related expenses. An additional $4.4 million was paid for related inventory.

Page 7

INTER PARFUMS, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

The cost of the acquisition was paid in cash on the closing date and was financed entirely through a 5-year term loan payable in equal quarterly installments plus interest. This term loan requires the maintenance of certain financial covenants, tested semi-annually, including a maximum leverage ratio and a minimum interest coverage ratio. The facility also contains new debt restrictions among other standard provisions. The Company is in compliance with all of the covenants and other restrictions of the debt agreements. In order to reduce exposure to rising variable interest rates, the Company entered into a swap transaction effectively exchanging the variable interest rate to a fixed rate of approximately 1.2%. The swap is a derivative instrument and is therefore recorded at fair value and changes in fair value are reflected in the accompanying consolidated statements of income.

In April 2015, the Company, through its majority owned Paris-based subsidiary, Interparfums SA, entered into an 11-year exclusive worldwide license with Coach, Inc. to create, produce and distribute new perfumes and fragrance related products, including new men’s and women’s scents under the Coach brand name. Interparfums SA will distribute these fragrances globally to department stores, specialty stores and duty free shops, as well as in Coach retail stores beginning in 2016. The agreement is subject to certain minimum sales, advertising expenditures and royalty payments as are customary in our industry.

In July 2015, Interparfums SA formed a new subsidiary in Spain, Parfums Rochas. The subsidiary is 51% owned by Interparfums SA with the remaining 49% owned by its Rochas distributor for Spain. Parfums Rochas will be responsible for Rochas brand distribution in the territory.

Activity relating to trademarks, licenses and other intangible assets is as follows:

(In thousands)	September 30, 2015			December 31, 2014

Trademarks, licenses and other intangible assets – beginning of period	$	98,531		$	116,243
Trademarks, licenses and other intangible assets acquired		119,541			922
Amortization		(4,291	)		(6,595	)
Foreign currency translation adjustment		(6,125	)		(12,039	)

Trademarks, licenses and other intangible assets – end of period	$	207,656		$	98,531

Inventories:

Inventories consist of the following:

(In thousands)	September 30, 2015		December 31, 2014

Raw materials and component parts	$	28,664	$	36,383
Finished goods		78,327		65,943

	$	106,991	$	102,326

Page 8

INTER PARFUMS, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

Fair Value Measurement:

The following tables present our financial assets and liabilities that are measured at fair value on a recurring basis and are categorized using the fair value hierarchy. The fair value hierarchy has three levels based on the reliability of the inputs used to determine fair value.

(In thousands)			Fair Value Measurements at September 30, 2015
			Quoted Prices in		Significant Other		Significant
			Active Markets for		Observable		Unobservable
			Identical Assets		Inputs		Inputs
	Total		(Level 1)		(Level 2)		(Level 3)
Assets:
Short-term investments	$	90,219	$	—	$	90,219	$	—
Foreign currency forward exchange contracts not accounted for using hedge accounting		285		—		285		—

	$	90,504	$	—	$	90,504	$	—
Liabilities:
Interest rate swaps	$	670	$	—	$	670	$	—

			Fair Value Measurements at December 31, 2014
			Quoted Prices in		Significant Other		Significant
			Active Markets for		Observable		Unobservable
			Identical Assets		Inputs		Inputs
	Total		(Level 1)		(Level 2)		(Level 3)
Assets:
Short-term investments	$	190,152	$	—	$	190,152	$	—

Liabilities:
Foreign currency forward exchange contracts not accounted for using hedge accounting	$	355	$	—	$	355	$	—

The carrying amount of cash and cash equivalents including money market funds, accounts receivable, other receivables, accounts payable and accrued expenses approximates fair value due to the short terms to maturity of these instruments. The carrying amount of loans payable approximates fair value as the interest rates on the Company’s indebtedness approximate current market rates. The fair value of the Company’s long-term debt was estimated based on the current rates offered to companies for debt with the same remaining maturities and is approximately equal to its carrying value.

Foreign currency forward exchange contracts are valued based on quotations from financial institutions and the value of interest rate swaps are the discounted net present value of the swaps using third party quotes obtained from financial institutions.

Page 9

INTER PARFUMS, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

Derivative Financial Instruments:

The Company enters into foreign currency forward exchange contracts to hedge exposure related to receivables denominated in a foreign currency and occasionally to manage risks related to future transactions expected to be denominated in a foreign currency. In connection with the Rochas acquisition, $108 million of the purchase price was paid in cash on the closing date and was financed entirely through a 5-year term loan. As the payment at closing was due in dollars and we had planned to finance it with debt in euro, the Company entered into foreign currency exchange contracts to secure the exchange rate for the $108 million purchase price at $1.067 per 1 euro. This derivative was designated and qualified as a cash flow hedge. The Company did not have any other cash flow hedges during the three and nine months ended September 30, 2015 and 2014.

Gains and losses in derivatives not designated as hedges are included in loss on foreign currency on the accompanying income statement and were immaterial for the three and nine months ended September 30, 2015 and 2014. For the three and nine months ended September 30, 2015, the loss of $0.5 million and $0.7 million is from the interest rate swap and is included in interest income.

All derivative instruments are reported as either assets or liabilities on the balance sheet measured at fair value. The valuation of interest rate swaps resulted in a liability which is included in long-term debt on the accompanying balance sheet as of September 30, 2015. The valuation of foreign currency forward exchange contracts not accounted for using hedge accounting as of September 30, 2015 resulted in an asset and is included in other current assets, and at December 31, 2014 such valuation resulted in a liability and is included in accrued expenses on the accompanying balance sheet.

Generally, increases or decreases in the fair value of derivative instruments will be recognized as gains or losses in earnings in the period of change. If the derivative instrument is designated and qualifies as a cash flow hedge, the changes in fair value of the derivative instrument will be recorded as a separate component of shareholders’ equity.

At September 30, 2015, we had foreign currency contracts in the form of forward exchange contracts in the amount of approximately U.S. $14.6 million, GB pounds £4 million and JPY ¥115 million which all have maturities of less than one year.

Accrued Expenses:

Accrued expenses include approximately $11.8 million and $16.5 million in advertising liabilities as of September 30, 2015 and December 31, 2014, respectively.

Share-Based Payments:

The Company maintains a stock option program for key employees, executives and directors. The plans, all of which have been approved by shareholder vote, provide for the granting of both nonqualified and incentive options. Options granted under the plans typically have a six-year term and vest over a four to five-year period. The fair value of shares vested for both the nine months ended September 30, 2015 and 2014 aggregated $0.03 million. Compensation cost is recognized on a straight-line basis over the requisite service period for the entire award. It is generally our policy to issue new shares upon exercise of stock options.

Page 10

INTER PARFUMS, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

The following table sets forth information with respect to nonvested options for the nine month period ended September 30, 2015:

	Number of Shares			Weighted Average Grant Date Fair Value
Nonvested options – beginning of period		385,505		$	7.14
Nonvested options granted		14,000		$	6.73
Nonvested options vested or forfeited		(9,935	)	$	6.80
Nonvested options – end of period		389,570		$	7.14

Share-based payment expense decreased income before income taxes by $0.20 million and $0.59 million for the three and nine months ended September 30, 2015, respectively, as compared to $0.23 million and $0.69 million for the corresponding periods of the prior year. Share-based payment expense decreased income attributable to Inter Parfums, Inc. by $0.12 million and $0.35 million for the three and nine months ended September 30, 2015, respectively, as compared to $0.13 million and $0.38 million for the corresponding periods of the prior year.

The following table summarizes stock option information as of September 30, 2015:

	Shares			Weighted Average Exercise Price

Outstanding at January 1, 2015		639,495		$	23.19
Options granted		14,000			25.67
Options cancelled		(4,700	)		27.51
Options exercised		(27,915	)		16.18

Outstanding at September 30, 2015		620,880		$	23.53

Options exercisable		231,310		$	18.76
Options available for future grants		319,235

As of September 30, 2015, the weighted average remaining contractual life of options outstanding is 3.25 years (1.94 years for options exercisable), the aggregate intrinsic value of options outstanding and options exercisable is $2.6 million and $1.7 million, respectively, and unrecognized compensation cost related to stock options outstanding of Inter Parfums, Inc. aggregated $2.1 million.

Cash proceeds, tax benefits and intrinsic value related to stock options exercised during the nine months ended September 30, 2015 and September 30, 2014 were as follows:

(In thousands)	September 30, 2015		September 30, 2014

Cash proceeds from stock options exercised	$	451	$	861
Tax benefits		—		—
Intrinsic value of stock options exercised		482		1,631

Page 11

INTER PARFUMS, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

The weighted average fair values of the options granted by Inter Parfums, Inc. during the nine months ended September 30, 2015 and 2014 were $6.73 and $8.47 per share, respectively, on the date of grant using the Black-Scholes option pricing model to calculate the fair value of options granted.

The assumptions used in the Black-Scholes pricing model for the periods ended September 30, 2015 and 2014 are set forth in the following table:

	September 30, 2015			September 30, 2014

Weighted average expected stock-price volatility		34	%		37	%
Weighted average expected option life		5 years			5 years
Weighted average risk-free interest rate		1.28	%		1.60	%
Weighted average dividend yield		1.8	%		2.4	%

Expected volatility is estimated based on historic volatility of the Company’s common stock. The expected term of the option is estimated based on historic data. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of the grant of the option and the dividend yield reflects the assumption that the dividend payout as authorized by the Board of Directors would increase as the earnings of the Company and its stock price increases.

Net Income Attributable to Inter Parfums, Inc. Common Shareholders:

Net income attributable to Inter Parfums, Inc. per common share (“basic EPS”) is computed by dividing net earnings attributable to Inter Parfums, Inc. by the weighted average number of shares outstanding. Net earnings attributable to Inter Parfums, Inc. per share assuming dilution (“diluted EPS”), is computed using the weighted average number of shares outstanding, plus the incremental shares outstanding assuming the exercise of dilutive stock options using the treasury stock method.

Page 12

INTER PARFUMS, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

The reconciliation between the numerators and denominators of the basic and diluted EPS computations is as follows:

	Three months ended				Nine months ended
(In thousands)	September 30,				September 30,
	2015		2014		2015		2014
Numerator:
Net income attributable to Inter Parfums, Inc.	$	14,220	$	11,113	$	28,578	$	26,115
Effect of dilutive securities of consolidated subsidiary		—		—		—		—
Numerator for diluted earnings per share	$	14,220	$	11,113	$	28,578	$	26,115
Denominator:
Weighted average shares		31,005		30,941		30,991		30,927
Effect of dilutive securities:
Stock options		93		113		101		133
Denominator for diluted earnings per share		31,098		31,054		31,092		31,060

Earnings per share:
Net income attributable to Inter Parfums, Inc. common shareholders:
Basic	$	0.46	$	0.36	$	0.92	$	0.84
Diluted		0.46		0.36		0.92		0.84

Not included in the above computations is the effect of antidilutive potential common shares which consist of outstanding options to purchase 0.27 million shares and 0.13 million shares of common stock for the nine months ended September 30, 2015 and 2014, respectively, and 0.27 million and 0.13 million shares of common stock for the three months ended September 30, 2015 and 2014, respectively.

10.

Net Income Attributable to Inter Parfums, Inc. and Transfers From the Noncontrolling Interest:

(In thousands)	Three months ended September 30,				Nine months ended September 30,
	2015		2014		2015		2014

Net income attributable to Inter Parfums, Inc.	$	14,220	$	11,113	$	28,578	$	26,115
Decrease in Inter Parfums, Inc.’s additional paid-in capital for subsidiary share transactions		—		16		6		335
Change from net income attributable to Inter Parfums, Inc. and transfers from noncontrolling interest	$	14,220	$	11,097	$	28,572	$	25,780

Page 13

INTER PARFUMS, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

11.

Segment and Geographic Areas:

The Company manufactures and distributes one product line, fragrances and fragrance related products. The Company manages its business in two segments, European based operations and United States based operations. The European assets are located, and operations are primarily conducted, in France. European operations primarily represent the sale of prestige brand name fragrances and United States operations primarily represent the sale of prestige brand and specialty retail fragrances.

Information on our operations by geographical areas is as follows:

(In thousands)	Three months ended September 30,						Nine months ended September 30,
	2015			2014			2015			2014
Net sales:
United States	$	28,770		$	30,784		$	76,123		$	73,718
Europe		110,204			103,457			274,212			300,506
Eliminations		(30	)		(35	)		(121	)		(95	)

	$	138,944		$	134,206		$	350,214		$	374,129

Net income attributable to Inter Parfums, Inc.:
United States	$	2,537		$	2,705		$	4,886		$	4,042
Europe		11,683			8,408			23,692			22,073

	$	14,220		$	11,113		$	28,578		$	26,115

	September 30,			December 31,
	2015			2014
Total Assets:
United States	$	81,599		$	78,740
Europe		622,429			535,049
Eliminations of investment in subsidiary		(9,125	)		(9,283	)

	$	694,903		$	604,506

12.

Income Taxes:

The Company is undergoing a tax audit by the French Tax Authorities; it is too early to assess whether or not this audit will have any impact on the Company’s financial statements.

Page 14

INTER PARFUMS, INC. AND SUBSIDIARIES

Item 2:

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Forward Looking Information

Statements in this report which are not historical in nature are forward-looking statements. Although we believe that our plans, intentions and expectations reflected in such forward-looking statements are reasonable, we can give no assurance that such plans, intentions or expectations will be achieved. In some cases you can identify forward-looking statements by forward-looking words such as "anticipate," "believe," "could," "estimate," "expect," "intend," "may," "should," "will" and "would" or similar words. You should not rely on forward-looking statements because actual events or results may differ materially from those indicated by these forward-looking statements as a result of a number of important factors. These factors include, but are not limited to, the risks and uncertainties discussed under the headings “Forward Looking Statements” and "Risk Factors" in Inter Parfums' annual report on Form 10-K for the fiscal year ended December 31, 2014 and the reports Inter Parfums files from time to time with the Securities and Exchange Commission. Inter Parfums does not intend to and undertakes no duty to update the information contained in this report.

Overview

We operate in the fragrance business, and manufacture, market and distribute a wide array of fragrances and fragrance related products. We manage our business in two segments, European based operations and United States based operations. Certain prestige fragrance products are produced and marketed by our European operations through our 73% owned subsidiary in Paris, Interparfums SA, which is also a publicly traded company as 27% of Interparfums SA shares trade on the NYSE Euronext.

We produce and distribute our European based prestige products primarily under license agreements with brand owners, and European based prestige product sales represented approximately 78% and 80% of net sales for the nine months ended September 30, 2015 and 2014, respectively. We have built a portfolio of prestige brands, which include Balmain, Boucheron, Coach, Jimmy Choo, Karl Lagerfeld, Lanvin, Montblanc, Paul Smith, S.T. Dupont, Repetto, Rochas and Van Cleef & Arpels, whose products are distributed in over 100 countries around the world. We own the Lanvin brand name for our class of trade, and license the Montblanc and Jimmy Choo brand names; for the nine months ended September 30, 2015, sales of product for these brands represented 15%, 22%, and 20% of net sales, respectively.

Through our United States operations, we also market prestige brands as well as specialty retail fragrance and fragrance related products. United States operations represented 22% and 20% of net sales for the nine months ended September 30, 2015 and 2014, respectively. These fragrance products are sold or are to be sold under trademarks owned by us or pursuant to license or other agreements with the owners of the Anna Sui, Abercrombie & Fitch, Agent Provocateur, Anna Sui, Banana Republic, bebe, Dunhill, Hollister, Oscar de la Renta, and Shanghai Tang brands.

Quarterly sales fluctuations are influenced by the timing of new product launches as well as the third and fourth quarters holiday season. In certain markets where we sell directly to retailers, seasonality is more evident. We sell directly to retailers in France as well as through our own distribution subsidiaries in Italy, Germany, Spain, and the United States.

Page 15

INTER PARFUMS, INC. AND SUBSIDIARIES

We grow our business in two distinct ways. First, we grow by adding new brands to our portfolio, either through new licenses, other arrangements or out-right acquisitions of brands. Second, we grow through the introduction of new products and supporting new and established products through advertising, merchandising and sampling, as well as phasing out existing products that no longer meet the needs of our consumers. The economics of developing, producing, launching and supporting products influence our sales and operating performance each year. Our introduction of new products may have some cannibalizing effect on sales of existing products, which we take into account in our business planning.

Our business is not capital intensive, and it is important to note that we do not own manufacturing facilities. We act as a general contractor and source our needed components from our suppliers. These components are received at one of our distribution centers and then, based upon production needs, the components are sent to one of several third party fillers which manufacture the finished product for us and then deliver them to one of our distribution centers.

As with any global business, many aspects of our operations are subject to influences outside our control. We believe we have a strong brand portfolio with global reach and potential. As part of our strategy, we plan to continue to make investments behind fast-growing markets and channels to grow market share.

During the nine months ended September 30, 2015, the economic uncertainty and financial market volatility taking place in certain European countries, the Middle East, China and Brazil, had a small negative impact on our business, and at this time we do not believe it will significantly affect our overall business for the foreseeable future. However, if the degree of uncertainty or volatility worsens or is prolonged, then there will likely be a negative effect on ongoing consumer confidence, demand and spending and as a result, our business. Currently, we believe general economic and other uncertainties still exist in select markets in which we do business, and we continue to monitor global economic uncertainties and other risks that may affect our business.

Our reported net sales are impacted by changes in foreign currency exchange rates. A strong U.S. dollar has a negative impact on our net sales. However, earnings are positively affected by a strong dollar, because almost 50% of net sales of our European operations are denominated in U.S. dollars, while almost all costs of our European operations are incurred in euro. Our Company addresses certain financial exposures through a controlled program of risk management that includes the use of derivative financial instruments. We primarily enter into foreign currency forward exchange contracts to reduce the effects of fluctuating foreign currency exchange rates.

Page 16

INTER PARFUMS, INC. AND SUBSIDIARIES

Recent Important Events

Montblanc

Rochas

The cost of the acquisition was paid in cash on the closing date and was financed entirely through a 5-year term loan payable in equal quarterly installments plus interest. In order to reduce exposure to rising variable interest rates, the Company entered into a swap transaction effectively exchanging the variable interest rate to a fixed rate of approximately 1.2%. The swap is a derivative instrument and is therefore recorded at fair value and changes in fair value are reflected in the accompanying consolidated statements of income.

Coach

Page 17

INTER PARFUMS, INC. AND SUBSIDIARIES

Abercrombie & Fitch and Hollister

In December 2014, the Company entered into a 7-year exclusive worldwide license to create, produce and distribute new perfumes and fragrance related products under the Abercrombie & Fitch and Hollister brand names. The Company will distribute these fragrances internationally in specialty retailers, high-end department stores and duty free shops, and in the U.S., in duty free shops and potentially in Abercrombie & Fitch and Hollister retail stores. The agreement is subject to certain minimum sales, advertising expenditures and royalty payments as are customary in our industry. New men’s and women’s scents are planned for both Abercrombie & Fitch and Hollister for 2016.

Discussion of Critical Accounting Policies

We make estimates and assumptions in the preparation of our financial statements in conformity with accounting principles generally accepted in the United States of America. Actual results could differ significantly from those estimates under different assumptions and conditions. We believe the following discussion addresses our most critical accounting policies, which are those that are most important to the portrayal of our financial condition and results of operations. These accounting policies generally require our management’s most difficult and subjective judgments, often as a result of the need to make estimates about the effect of matters that are inherently uncertain. Management of the Company has discussed the selection of significant accounting policies and the effect of estimates with the Audit Committee of the Board of Directors.

Revenue Recognition

We sell our products to department stores, perfumeries, specialty retailers, mass-market retailers, supermarkets and domestic and international wholesalers and distributors. Sales of such products by our domestic subsidiaries are denominated in U.S. dollars and sales of such products by our foreign subsidiaries are primarily denominated in either euro or U.S. dollars. We recognize revenues when merchandise is shipped and the risk of loss passes to the customer. Net sales are comprised of gross revenues less returns, trade discounts and allowances.

Accounts Receivable

Accounts receivable represent payments due to the Company for previously recognized net sales, reduced by allowances for sales returns and doubtful accounts. Accounts receivable balances are written-off against the allowance for doubtful accounts when they become uncollectible. Recoveries of accounts receivable previously recorded against the allowance are recorded in the consolidated statement of income when received. We generally grant credit based upon our analysis of the customer’s financial position as well as previously established buying patterns.

Page 18

INTER PARFUMS, INC. AND SUBSIDIARIES

Sales Returns

Generally, we do not permit customers to return their unsold products. However, for U.S. distribution of our prestige products, we allow returns if properly requested, authorized and approved. We regularly review and revise, as deemed necessary, our estimate of reserves for future sales returns based primarily upon historic trends and relevant current data, including information provided by retailers regarding their inventory levels. In addition, as necessary, specific accruals may be established for significant future known or anticipated events. The types of known or anticipated events that we have considered, and will continue to consider, include, but are not limited to, the financial condition of our customers, store closings by retailers, changes in the retail environment and our decision to continue to support new and existing products. We record estimated reserves for sales returns as a reduction of sales, cost of sales and accounts receivable. Returned products are recorded as inventories and are valued based upon estimated realizable value. The physical condition and marketability of returned products are the major factors we consider in estimating realizable value. Actual returns, as well as estimated realizable values of returned products, may differ significantly, either favorably or unfavorably, from our estimates, if factors such as economic conditions, inventory levels or competitive conditions differ from our expectations.

Inventories

Inventories are stated at the lower of cost or market value. Cost is principally determined by the first-in, first-out method. We record adjustments to the cost of inventories based upon our sales forecast and the physical condition of the inventories. These adjustments are estimates, which could vary significantly, either favorably or unfavorably, from actual requirements if future economic conditions or competitive conditions differ from our expectations.

Equipment and Other Long-Lived Assets

Equipment, which includes tools and molds, is recorded at cost and is depreciated on a straight-line basis over the estimated useful lives of such assets. Changes in circumstances such as technological advances, changes to our business model or changes in our capital spending strategy can result in the actual useful lives differing from our estimates. In those cases where we determine that the useful life of equipment should be shortened, we would depreciate the net book value in excess of the salvage value, over its revised remaining useful life, thereby increasing depreciation expense. Factors such as changes in the planned use of equipment, or market acceptance of products, could result in shortened useful lives.

We evaluate indefinite-lived intangible assets for impairment at least annually during the fourth quarter, or more frequently when events occur or circumstances change, such as an unexpected decline in sales, that would more likely than not indicate that the carrying value of an indefinite-lived intangible asset may not be recoverable. When testing indefinite-lived intangible assets for impairment, the evaluation requires a comparison of the estimated fair value of the asset to the carrying value of the asset. The fair values used in our evaluations are estimated based upon discounted future cash flow projections using a weighted average cost of capital of 6.7%. The cash flow projections are based upon a number of assumptions, including, future sales levels and future cost of goods and operating expense levels, as well as economic conditions, changes to our business model or changes in consumer acceptance of our products which are more subjective in nature. If the carrying value of an indefinite-lived intangible asset exceeds its fair value, an impairment charge is recorded.

We believe that the assumptions we have made in projecting future cash flows for the evaluations described above are reasonable and currently no impairment indicators exist for our indefinite-lived intangible assets. However, if future actual results do not meet our expectations, we may be required to record an impairment charge, the amount of which could be material to our results of operations.

Page 19

INTER PARFUMS, INC. AND SUBSIDIARIES

The following table presents the impact a change in the following significant assumptions would have had on the calculated fair value in 2014 assuming all other assumptions remained constant:

In millions				Increase (decrease)
	Change			to fair value

Weighted average cost of capital		+10	%	$	(1.0	)
Weighted average cost of capital		-10	%	$	1.3
Future sales levels		+10	%	$	1.0
Future sales levels		-10	%	$	(1.0	)

Intangible assets subject to amortization are evaluated for impairment testing whenever events or changes in circumstances indicate that the carrying amount of an amortizable intangible asset may not be recoverable. If impairment indicators exist for an amortizable intangible asset, the undiscounted future cash flows associated with the expected service potential of the asset are compared to the carrying value of the asset. If our projection of undiscounted future cash flows is in excess of the carrying value of the intangible asset, no impairment charge is recorded. If our projection of undiscounted future cash flows is less than the carrying value of the intangible asset, an impairment charge would be recorded to reduce the intangible asset to its fair value. The cash flow projections are based upon a number of assumptions, including future sales levels and future cost of goods and operating expense levels, as well as economic conditions, changes to our business model or changes in consumer acceptance of our products which are more subjective in nature. We believe that the assumptions we have made in projecting future cash flows for the evaluations described above are reasonable and currently no impairment indicators exist for our intangible assets subject to amortization. In those cases where we determine that the useful life of long-lived assets should be shortened, we would depreciate the net book value in excess of the salvage value (after testing for impairment as described above), over the revised remaining useful life of such asset thereby increasing amortization expense.

In determining the useful life of our Lanvin brand names and trademarks, we applied the provisions of ASC topic 350-30-35-3. The only factor that prevented us from determining that the Lanvin brand names and trademarks were indefinite life intangible assets was Item c. “Any legal, regulatory, or contractual provisions that may limit the useful life.” The existence of a repurchase option in 2025 may limit the useful life of the Lanvin brand names and trademarks to the Company. However, this limitation would only take effect if the repurchase option were to be exercised and the repurchase price was paid. If the repurchase option is not exercised, then the Lanvin brand names and trademarks are expected to continue to contribute directly to the future cash flows of our Company and their useful life would be considered to be indefinite.

With respect to the application of ASC topic 350-30-35-8, the Lanvin brand names and trademarks would only have a finite life to our Company if the repurchase option were exercised, and in applying ASC topic 350-30-35-8 we assumed that the repurchase option is exercised. When exercised, Lanvin has an obligation to pay the exercise price and the Company would be required to convey the Lanvin brand names and trademarks back to Lanvin. The exercise price to be received (Residual Value) is well in excess of the carrying value of the Lanvin brand names and trademarks, therefore no amortization is required.

Page 20

INTER PARFUMS, INC. AND SUBSIDIARIES

Derivatives

We account for derivative financial instruments in accordance with ASC topic 815, which establishes accounting and reporting standards for derivative instruments, including certain derivative instruments embedded in other contracts, and for hedging activities. This topic also requires the recognition of all derivative instruments as either assets or liabilities on the balance sheet and that they are measured at fair value.

We currently use derivative financial instruments to hedge certain anticipated transactions and interest rates, as well as receivables denominated in foreign currencies. We do not utilize derivatives for trading or speculative purposes. Hedge effectiveness is documented, assessed and monitored by employees who are qualified to make such assessments and monitor the instruments. Variables that are external to us such as social, political and economic risks may have an impact on our hedging program and the results thereof.

Income Taxes

The Company accounts for income taxes using an asset and liability approach that requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been recognized in its financial statements or tax returns. The net deferred tax assets assume sufficient future earnings for their realization, as well as the continued application of currently anticipated tax rates. Included in net deferred tax assets is a valuation allowance for deferred tax assets, where management believes it is more-likely-than-not that the deferred tax assets will not be realized in the relevant jurisdiction. If the Company determines that a deferred tax asset will not be realizable, an adjustment to the deferred tax asset will result in a reduction of net earnings at that time. In addition, the Company follows the provisions of uncertain tax positions as addressed in ASC topic 740-10-65-1.

Results of Operations

Three and Nine Months Ended September 30, 2015 as Compared to the Three and Nine Months Ended September 30, 2014

Net Sales

(In millions)

	Three months ended September 30,							Nine months ended September 30,
	2015		2014		% Change			2015		2014		% Change

European based brand product sales	$	110.1	$	103.4		6.5	%	$	274.1	$	300.4		-8.8	%
United States based product sales		28.8		30.8		-6.5	%		76.1		73.7		3.3	%
Total net sales	$	138.9	$	134.2		3.5	%	$	350.2	$	374.1		-6.4	%

Page 21

INTER PARFUMS, INC. AND SUBSIDIARIES

Net sales for the three months ended September 30, 2015 increased 3.5% to $138.9 million, as compared to $134.2 million for the corresponding period of the prior year. At comparable foreign currency exchange rates, net sales increased 11.4%. Net sales for the nine months ended September 30, 2015 decreased 6.4% to $350.2 million, as compared to $374.1 million for the corresponding period of the prior year. At comparable foreign currency exchange rates, net sales increased 1.7% for the period.

European based prestige product sales increased 6.5% and decreased 8.8% for the three and nine months ended September 30, 2015, respectively as compared to the corresponding periods of the prior year. At comparable foreign currency exchange rates, European based prestige product sales increased 16.8% and 1.3% for the three and nine months ended September 30, 2015, respectively. The 16% to 19% depreciation range of the euro versus the dollar for each of the first three quarters of 2015 has taken its toll on reported sales. Most recently, the currency impact was most apparent with our three largest brands, led by Jimmy Choo, where brand sales for the three months ended September 30, 2015 increased 46% in local currency, but only 23% in dollars, as compared to the corresponding period of the prior year. The excellent performance in Jimmy Choo fragrance sales reflects robust gains from the Jimmy Choo Man line, particularly in the United States, and the recent and promising launch of the Jimmy Choo Illicit line, the brand's third women's fragrance initiative. Montblanc sales comparison was more favorable in the third quarter than in the first half, with brand sales up 25% in local currency and 5% in dollars, driven by the successes of the Legend and Emblem lines and initial sales for the Lady Emblem line. Lanvin brand sales rebounded in the third quarter, up 7% in local currency but down 10% in dollars.

Irrespective of a weaker euro, we maintain confidence in our future as we have strengthened advertising and promotional investments supporting our portfolio brands and accelerated brand development. Our expectations reflect plans to continue to build upon the strength of our brands and our worldwide distribution network. We are also encouraged from our recent new product launches. The release of Jimmy Choo Illicit promises to build on the strong results we’ve generated with the Jimmy Choo brand. The unveiling of Lady Emblem during the second half of 2015, has helped boost Montblanc sales. Lanvin sales should also continue to benefit from its recent introduction of a new scent for women, Eclat de Fleurs.

For the remainder of 2015, although we anticipate strong performances from our major European based prestige brands, our optimism is somewhat tempered by the negative market conditions seen in China, Eastern Europe and most recently, Brazil, which we expect to continue in the near-term.

United States based product sales decreased 6.5% but increased 3.3% for the three and nine months ended September 30, 2015, respectively as compared to the corresponding periods of the prior year. Dunhill fragrances had an exceptionally strong performance with brand sales up 39% and 50% for the three and nine months ended September 30, 2015, respectively, as compared to the corresponding periods of the prior year. The success of the 2015 launch of Dunhill Icon has enabled Dunhill to quickly become our largest brand within our United States operations with sales for the nine months ended September 30, 2015 reaching $16.7 million. Oscar de la Renta brand sales were down by 6% for the quarter, but up nearly 35% year-to-date, aggregating $14.3 million for the nine months ended September 30, 2015, benefitting from the 2015 launch of Extraordinary by Oscar de la Renta. We anticipate the growth trend to resume for Oscar de la Renta brand sales in the fourth quarter of 2015. Sales of Anna Sui fragrances, which were down nearly 19% from last year’s third quarter, continue to be depressed by negative market conditions in China.

Page 22

INTER PARFUMS, INC. AND SUBSIDIARIES

Net Sales to Customers by Region

(In millions)

	Nine months ended September 30,
	2015		2014

North America	$	94.3	$	97.6
Western Europe		91.9		98.8
Eastern Europe		29.9		31.1
Central and South America		31.0		38.9
Middle East		36.2		34.3
Asia		58.3		65.1
Other		8.6		8.3
	$	350.2	$	374.1

The chart above demonstrates the effect of negative market conditions in China, Eastern Europe and South America. The decline in Western Europe in 2015 includes the effect of the 18% devaluation of the euro against the dollar and the difficult comparison for Karl Lagerfeld brand sales in 2015 compared to the initial launch of that brand in the 2014 period.

We are actively pursuing other new business opportunities. However, we cannot assure you that any new licenses, acquisitions or specialty retail agreements will be consummated.

Gross margin	Three months ended September 30,						Nine months ended September 30,
(In millions)	2015			2014			2015			2014

Net sales	$	138.9		$	134.2		$	350.2		$	374.1
Cost of sales		53.1			58.9			136.4			161.4

Gross margin	$	85.8		$	75.3		$	213.8		$	212.7
Gross margin as a percent of net sales		62	%		56	%		61	%		57	%

Gross profit margin was 62% and 61% for the three and nine months ended September 30, 2015, respectively, as compared to 56% and 57% for the corresponding periods of the prior year. For European operations, gross profit margin was 64.8% and 64.2% for the three and nine months ended September 30, 2015, respectively, as compared to 58.7% and 59.3% for the corresponding periods of the prior year. The margin fluctuation for European operations is directly related to currency fluctuation. We carefully monitor movements in foreign currency exchange rates as almost 50% of our European based operations net sales are denominated in U.S. dollars, while most of our costs are incurred in euro. From a margin standpoint, a strong U.S. dollar has a positive effect on our gross margin while a weak U.S. dollar has a negative effect. The average dollar/euro exchange rate for both the three and nine months ended September 30, 2015 was 1.11, as compared to 1.33 and 1.35 for the three and nine months ended September 30, 2014, respectively.

Page 23

INTER PARFUMS, INC. AND SUBSIDIARIES

For U.S. operations, gross profit margin was 50.3% and 49.6% for the three and nine months ended September 30, 2015, respectively, as compared to 47.4% and 46.8% for the corresponding period of the prior year. The increases are primarily the result of a shift in product mix during the period as sales growth for our U.S. operations has primarily come from our higher margin prestige product licenses, such as Oscar de la Renta and Dunhill, while sales of lower margin specialty retail and mass market products have been in a decline. This trend is expected to continue, although some quarterly fluctuations can occur.

Generally, we do not bill customers for shipping and handling costs, and such costs, which aggregated $1.3 million and $3.6 million for the three and nine month ended September 30, 2015, respectively, as compared to $1.4 million and $3.8 million for the corresponding periods of the prior year, are included in selling, general and administrative expenses in the consolidated statements of income. As such, our Company’s gross profit may not be comparable to other companies, which may include these expenses as a component of cost of goods sold.

Selling, general and administrative expenses	Three months ended September 30,						Nine months ended September 30,
(In millions)	2015			2014			2015			2014

Selling, general and administrative expenses	$	58.2		$	56.6		$	156.8		$	163.7
Selling, general and administrative expenses as a percent of net sales		42	%		42	%		45	%		44	%

Selling, general and administrative expenses increased 2.7% and decreased 4.2% for the three and nine months ended September 30, 2015, respectively, as compared to the corresponding periods of the prior year. Selling, general and administrative expenses were 42% and 45% of net sales for the three and nine months ended September 30, 2015, as compared to 42% and 44% for the corresponding periods of the prior year. For European operations, selling, general and administrative expenses increased 3% but decreased 7% for the three and nine months ended September 30, 2015, respectively, as compared to the corresponding periods of the prior year and represented 43% and 46% of sales for the three and nine months ended September 30, 2015, as compared to 44% and 45% for the corresponding periods of the prior year. With constant currency sales up 16.8% and 1.3% for the three and nine months ended September 30, 2015, respectively, we can see the potential for leverage over our fixed expenses. For U.S. operations, while sales decreased 6.5% but increased 3.3% for the three and nine months ended September 30, 2015, respectively, as compared to the corresponding periods of the prior year, selling, general and administrative expenses increased 0.9% and 7.0% for the three and nine months ended September 30, 2015. This increase is the result of sales growth from our U.S. operations coming primarily from our newest, prestige product licenses, such as Oscar de la Renta and Dunhill, which bear royalty and advertising expenses.

Promotion and advertising included in selling, general and administrative expenses aggregated $21.2 million and $51.4 million for the three and nine months ended September 30, 2015, respectively, as compared to $20.7 million and $55.5 million for the corresponding periods of the prior year. Promotion and advertising represented 15.3% and 15.5% of net sales for the three months ended September 30, 2015 and 2014, and represented 14.7% and 14.8% of net sales for the nine months ended September 30, 2015 and 2014. Promotion and advertising expense has been very consistent on a period by period basis and once again, is expected to represent a much higher percentage of sales in the fourth quarter 2015. In 2013 and 2014, promotion and advertising represented approximately 34% and 25% of fourth quarter sales, respectively.

Page 24

INTER PARFUMS, INC. AND SUBSIDIARIES

Royalty expense included in selling, general and administrative expenses aggregated $9.5 million and $25.7 million for the three and nine months ended September 30, 2015, respectively, as compared to $9.9 million and $25.8 million for the corresponding periods of the prior year. Royalty expense represented 6.8% and 7.3% of net sales for the three and nine months ended September 30, 2015, as compared to 7.4% and 6.9% of net sales for the corresponding period of the prior year. These fluctuations are the result of the timing of accruals in 2014 and 2015 relating to the June 2015 settlement with Burberry regarding our royalty liability. Based on current data, we anticipate royalty expense to approximate 7% of net sales per year.

Service fees relating to the activities of our distribution subsidiaries aggregated $3.8 million and $8.4 million for the three and nine months ended September 30, 2015, respectively, as compared to $2.2 million and $7.8 million for the corresponding periods of the prior year. Approximately $0.6 million of the current period increase is the result of the addition of another distribution subsidiary in Spain, Parfums Rochas. The balance is due to increased sales from our U.S. distribution subsidiary.

As a result of the above analysis regarding margins and selling, general and administrative expenses, income from operations increased 48% to $27.6 million for the three months ended September 30, 2015, as compared to $18.7 million for the corresponding period of the prior year. Income from operations increased 16% to $56.9 million for the nine months ended September 30, 2015, as compared to $49.0 million for the corresponding period of the prior year. Operating margins were 19.9% and 16.3% of net sales for the three and nine months ended September 30, 2015, respectively, as compared to 13.9% and 13.1% for the corresponding periods of the prior year.

Other Income and Expense

Interest expense aggregated $1.0 million and $1.8 million for the three and nine months ended September 30, 2015, respectively, as compared to $0.6 million and $1.4 million for the corresponding period of the prior year. The increase is primarily related to the financing of the Rochas brand acquisition. We use the credit lines available to us, as needed, to finance our working capital needs as well as our financing needs for brand acquisitions.

Foreign currency gain (loss) aggregated $0.3 and ($1.8) million for the three and nine months ended September 30, 2015, respectively, as compared to a gain of $1.1 million for both corresponding periods of the prior year. The volatility in currency exchange rates during the first quarter of 2015 had not been seen in many years. The loss incurred during the nine months ended September 30, 2015, primarily represents losses from intercompany accounts between our majority owned subsidiary, Interparfums SA, and its other foreign subsidiaries, which were not hedged by the use of foreign currency forward exchange contracts. We typically enter into foreign currency forward exchange contracts to manage exposure related to receivables from unaffiliated third parties denominated in a foreign currency and occasionally to manage risks related to future sales expected to be denominated in a foreign currency. Almost 50% of net sales of our European operations are denominated in U.S. dollars.

Page 25

INTER PARFUMS, INC. AND SUBSIDIARIES

Interest income aggregated $0.9 million and $2.8 million for the three and nine months ended September 30, 2015, respectively, as compared to $0.9 million and $3.0 million for the corresponding periods of the prior year. Cash and cash equivalents and short-term investments are primarily invested in certificates of deposit with varying maturities.

Income Taxes

Our effective income tax rate was 33% for both the three and nine months ended September 30, 2015, respectively, as compared to 32% and 35% for the corresponding periods of the prior year. Overall, effective tax rates have been declining due to changes in allocation percentages related to state and local taxes of our U.S. operations and we continue to benefit from parts of our European operations that are located in lower tax jurisdictions. We expect our annual effective rate for 2015 to come in at approximately 33% to 34%. Our effective tax rates differ from statutory rates due to the effect of state and local taxes and tax rates in foreign jurisdictions. The Company is undergoing a tax audit by the French Tax Authorities; it is too early to assess whether or not this audit will have any impact on our financial statements.

Net income and earnings per share

(In thousands except per share data)	Three Months Ended September 30,				Nine Months Ended September 30,
	2015		2014		2015		2014

Net income European operations	$	16,097	$	11,059	$	32,573	$	29,538
Net income U.S. operations		2,537		2,705		4,886		4,042

Net income		18,634		13,764		37,459		33,580

Less: Net income attributable to the noncontrolling interest		4,414		2,651		8,881		7,465

Net income attributable to Inter Parfums, Inc.	$	14,220	$	11,113	$	28,578	$	26,115

Earnings per share:

Net income attributable to Inter Parfums, Inc. common shareholders:
Basic	$	0.46	$	0.36	$	0.92	$	0.84
Diluted	$	0.46	$	0.36	$	0.92	$	0.84

Weighted average number of shares outstanding:
Basic		31,005		30,941		30,991		30,927
Diluted		31,098		31,054		31,092		31,060

Net income increased 35% to $18.6 million for the three months ended September 30, 2015, as compared to $13.8 million for the corresponding period of the prior year. Net income increased 12% to $37.5 million for the nine months ended September 30, 2015, as compared to $33.6 million for the corresponding period of the prior year. The reasons for fluctuations in net income for both European operations and United States operations are directly related to the previous discussions relating to changes in sales, gross margin and selling, general and administrative expenses. As previously discussed, our European operations reported net sales are affected by changes in foreign currency exchange rates, as a strong U.S. dollar has a negative impact on reported net sales. However, earnings are positively affected by a strong U.S. dollar, because almost 50% of net sales of our European operations are denominated in U.S. dollars, while almost all costs of our European operations are incurred in euro. For United States operations during the nine months ended September 30, 2015, sales increased 3% while selling, general and administrative expenses increased 7%. Therefore, the increase in net income for the nine month period is primarily the result of the increase in gross margin.

Page 26

INTER PARFUMS, INC. AND SUBSIDIARIES

The noncontrolling interest arises from our 73% owned subsidiary in Paris, Interparfums SA, which is also a publicly traded company as 27% of Interparfums SA shares trade on the NYSE Euronext. Net income attributable to the noncontrolling interest is directly related to the profitability of our European operations, and aggregated 27% of European operations net income for the three and nine months ended September 30, 2015, respectively, as compared to 24% and 25% for the corresponding periods of the prior year.

Liquidity and Capital Resources

The Company’s financial position remains strong. At September 30, 2015, working capital aggregated $353 million and we had a working capital ratio of over 4.0 to 1. Cash and cash equivalents and short-term investments aggregated $215 million, practically all of which is held in euro by our European operations and is readily convertible into U.S. dollars. We have not had any liquidity issues to date, and do not expect any liquidity issues relating to such cash and cash equivalents and short-term investments held by our European operations. Almost 90% of the Company’s total assets are held by European operations. In addition to the cash and cash equivalents and short-term investments referred to above, approximately $196 million of trademarks, licenses and other intangible assets are held by European operations.

The Company hopes to benefit from its substantial resources to potentially acquire additional brands either on a proprietary basis or as a licensee. Opportunities for external growth continue to be examined without urgency, with the priority of maintaining the quality and homogeneous nature of our portfolio. However, we cannot assure you that any new license or acquisition agreements will be consummated.

Cash used in operating activities was $12.5 million for the nine months ended September 30, 2015, as compared to $13.2 million for the nine months ended September 30, 2014. For the 2015 period, working capital items used $57.5 million in cash from operating activities, as compared to $54.8 million in the 2014 period. The only significant fluctuations for both periods relate to increases in accounts receivables as of the end of September as compared to that at the end of December. This reflects the seasonality in our business whereby sales in the third quarter are significantly higher than those in the fourth quarter.

Cash flows used in investing activities in 2015 reflect the purchase and sales, in our European operations, of short-term investments. These investments are primarily certificates of deposit with maturities greater than three months. Approximately $88.5 million of such certificates of deposit contain penalties where we would forfeit a portion of the interest earned in the event of early withdrawal. Our business is not capital intensive as we do not own any manufacturing facilities. However, on a full year basis, we spend approximately $4 million on tools and molds, depending on our new product development calendar. Capital expenditures also include amounts for office fixtures, computer equipment and industrial equipment needed at our distribution centers.

Page 27

INTER PARFUMS, INC. AND SUBSIDIARIES

Our short-term financing requirements are expected to be met by available cash on hand at September 30, 2015, cash generated by operations and short-term credit lines provided by domestic and foreign banks. The principal credit facilities for 2015 consist of a $20.0 million unsecured revolving line of credit provided by a domestic commercial bank and approximately $28.0 million in credit lines provided by a consortium of international financial institutions.

In January 2015, the Board of Directors authorized an 8% increase in the annual dividend to $0.52 per share. The next quarterly cash dividend of $0.13 per share is payable on January 15, 2016 to shareholders of record on December 31, 2015. The annual cash dividend for 2015 represents a small part of our cash position and is not expected to have any significant impact on our financial position.

We believe that funds provided by or used in operations can be supplemented by our present cash position and available credit facilities, so that they will provide us with sufficient resources to meet all present and reasonably foreseeable future operating needs.

Inflation rates in the U.S. and foreign countries in which we operate did not have a significant impact on operating results for the nine months ended September 30, 2015.

Item 3:

QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

General

We address certain financial exposures through a controlled program of risk management that primarily consists of the use of derivative financial instruments. We primarily enter into foreign currency forward exchange contracts in order to reduce the effects of fluctuating foreign currency exchange rates. We do not engage in the trading of foreign currency forward exchange contracts or interest rate swaps.

Page 28

INTER PARFUMS, INC. AND SUBSIDIARIES

Foreign Exchange Risk Management

We periodically enter into foreign currency forward exchange contracts to hedge exposure related to receivables denominated in a foreign currency and to manage risks related to future sales expected to be denominated in a currency other than our functional currency. We enter into these exchange contracts for periods consistent with our identified exposures. The purpose of the hedging activities is to minimize the effect of foreign exchange rate movements on the receivables and cash flows of Interparfums SA, our French subsidiary, whose functional currency is the euro. All foreign currency contracts are denominated in currencies of major industrial countries and are with large financial institutions, which are rated as strong investment grade.

All derivative instruments are required to be reflected as either assets or liabilities in the balance sheet measured at fair value. Generally, increases or decreases in fair value of derivative instruments will be recognized as gains or losses in earnings in the period of change. If the derivative is designated and qualifies as a cash flow hedge, then the changes in fair value of the derivative instrument will be recorded in other comprehensive income.

Before entering into a derivative transaction for hedging purposes, we determine that the change in the value of the derivative will effectively offset the change in the fair value of the hedged item from a movement in foreign currency rates. Then, we measure the effectiveness of each hedge throughout the hedged period. Any hedge ineffectiveness is recognized in the income statement.

At September 30, 2015, we had foreign currency contracts in the form of forward exchange contracts in the amount of approximately U.S. $14.6 million, GB pounds £4.0 million and JPY ¥115.0 million, which all have maturities of less than one year. We believe that our risk of loss as the result of nonperformance by any of such financial institutions is remote.

Interest Rate Risk Management

We mitigate interest rate risk by monitoring interest rates, and then determining whether fixed interest rates should be swapped for floating rate debt, or if floating rate debt should be swapped for fixed rate debt. We entered into an interest rate swap in June 2015 on €100 million of debt, effectively exchanging the variable interest rate to a fixed rate of approximately 1.2%. This derivative instrument is recorded at fair value and changes in fair value are reflected in the accompanying consolidated statements of income.

Item 4.

CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

Our Chief Executive Officer and Chief Financial Officer have reviewed and evaluated the effectiveness of our disclosure controls and procedures (as defined in the Securities Exchange Act of 1934 Rule 13a-15(e)) as of the end of the period covered by this quarterly report on Form 10-Q (the “Evaluation Date”). Based on their review and evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that as of the Evaluation Date, our Company's disclosure controls and procedures were effective.

Page 29

INTER PARFUMS, INC. AND SUBSIDIARIES

Changes in Internal Control Over Financial Reporting

There has been no change in our internal control over financial reporting (as defined in Rule 13a-15(f) of the Securities Exchange Act of 1934) that occurred during the quarterly period covered by this report on Form 10-Q that has materially affected, or is reasonably likely to materially affect, the Company's internal control over financial reporting. In 2015, the Company has implemented Internal Control – Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission.

Part II. Other Information

Items 1. Legal Proceedings, 1a. Risk Factors, 2. Unregistered Sales of Equity Securities and Use of Proceeds, 3. Defaults Upon Senior Securities, 4. Mine Safety Disclosures and 5. Other Information, are omitted as they are either not applicable or have been included in Part I.

Item 6.

Exhibits.

The following documents are filed herewith:

Exhibit No.	Description	Page Number

31.1	Certifications required by Rule 13a-14(a) of Chief Executive Officer	33

31.2	Certifications required by Rule 13a-14(a) of Chief Financial Officer	34

32.1	Certification required by Section 906 of the Sarbanes-Oxley Act of Chief Executive Officer	35

32.2	Certification required by Section 906 of the Sarbanes-Oxley Act of Chief Financial Officer	36

101	Interactive data files

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized on the 9th day of November 2015.

		INTER PARFUMS, INC.

	By:	/s/ Russell Greenberg
		Executive Vice President and
		Chief Financial Officer

Page 30

INTER PARFUMS, INC. AND SUBSIDIARIES

Exhibit 31.1

CERTIFICATIONS

I, Jean Madar, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Inter Parfums, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures as of the end of the period covered by this report based upon such evaluation; and

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth quarter in case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of registrant's board of directors (or persons performing the equivalent functions):

a) all significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: November 9, 2015

/s/ Jean Madar
Jean Madar,
Chief Executive Officer

INTER PARFUMS, INC. AND SUBSIDIARIES

Exhibit 31.2

I, Russell Greenberg, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Inter Parfums, Inc.;

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: November 9, 2015

/s/ Russell Greenberg
Russell Greenberg
Chief Financial Officer and
Principal Accounting Officer

INTER PARFUMS, INC. AND SUBSIDIARIES

Exhibit 32.1

CERTIFICATION

The undersigned hereby certifies, in accordance with 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, in his capacity as an officer of Inter Parfums, Inc., that the Quarterly Report of Inter Parfums, Inc. on Form 10-Q for the period ended September 30, 2015, fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934 and that the information contained in such report fairly presents, in all material respects, the financial condition and results of operation of Inter Parfums, Inc.

Date: November 9, 2015	By:	/s/ Jean Madar
		Jean Madar,
		Chief Executive Officer

A signed original of this written statement required by Section 906 has been provided to Inter Parfums, Inc. and will be retained by Inter Parfums, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

INTER PARFUMS, INC. AND SUBSIDIARIES

Exhibit 32.2

CERTIFICATION

Date: November 9, 2015	By:	/s/ Russell Greenberg
		Russell Greenberg
		Executive Vice President,
		Chief Financial Officer and
		Principal Accounting Officer

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

Create E-mail Alert Related Categories

SEC Filings

Sign up for StreetInsider Free!

Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!

Form 10-Q INTER PARFUMS INC For: Sep 30

You May Also Be Interested In

Create E-mail Alert Related Categories

Sign up for StreetInsider Free!

Free News Feed